A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Bellicum Pharmaceuticals
The First Affiliated Hospital of Soochow University
Roswell Park Cancer Institute
Kiadis Pharma
Cardiff University
M.D. Anderson Cancer Center
Gamida Cell -Teva Joint Venture Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Virginia Commonwealth University
Royal Marsden NHS Foundation Trust